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ABSTRACT
The administration of glucocorticoids is proven to cause serious adverse events. Objectives: This study was
conducted to compare the possible hazards of the short- and long-term administration of glucocorticoids on the
periodontium in rats, using histological examination and scanning electron microscopy. Methods: Fifteen adult
male albino rats were included in the study and divided into the 3 groups. Group I served as a control, group
II received 7 mg/kg dexamethasone intramuscularly once a week for 5 wk, and group III received 7 mg/kg
dexamethasone intramuscularly once a week for 10 wk. The mandibles were dissected and examined histologically
as well as with scanning electron microscopy and energy dispersive radiography. Results: Histologically, group
I showed normal an alveolar process. In group II, bone trabeculae demonstrated obvious Howship’s lacunae of
osteoclasts. In group III, bone trabeculae exhibited multiple degenerated osteocytes with apparent vacuolization.
Scanning electron microscopy revealed smooth alveolar bone architecture in group I. Groups II and III demonstrated
irregular bone architecture with widening of the neurovascular canals. EDX analysis demonstrated the highest
calcium-phosphorous concentration in the control group and the lowest in group III. Conclusions: Dexamethasone
has a devastating impact on the alveolar bone via the acceleration of bone resorption and decreased activity of
osteoblasts. This effect was more pronounced with prolonged drug administration.
Key words: electron microscopy, glucocorticoids, histology, periodontium
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INTRODUCTION

Osteoporosis (OP) is a common disorder characterized
by systemic bone loss and impaired bone micro
architecture that leads to increased bone fragility and
fracture susceptibility. Osteoporosis can ultimately
result from reduction of the estrogen level following
menopause, extended period of immobilization,
increasing age, chronic disorders, and use of certain
medicines.5 Bone loss is a characteristic feature of
osteoporosis that may encourage the development and
progression of periodontal disease as well as tooth loss.
At the bone level, many studies have focused on the link
between osteoporosis and periodontitis.6 Reduction in
bone mineral density (BMD) has also been reported
in various glucocorticoid treated pediatric disorders,
including asthma, organ transplantation, rheumatoid

Glucocorticoids (GC) are steroid hormones that
are physiologically produced by the adrenal glands
and are synthesized for sporadic or uninterrupted
systemic and topical use. Numerous biological
functions are regulated by glucocorticoids (GCs), such
as homeostasis, carbohydrate metabolism, protein
1
catabolism, evolution, awareness, and inflammation.
Moreover, GCs play a crucial role in acclimatization to
environmental alterations, stress reaction, and immune
modification.2–4 Synthetic glucocorticoids (GCs) have
been widely used in clinical practice for treating
autoimmune, rheumatic, and gastrointestinal disorders;
neoplasms; and organ transplantation for decades.
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METHODS

arthritis, and systemic lupus erythematosus.7 In
dentistry, inflammatory diseases, such as dental caries
and periodontitis, have been documented as a major
reason of the tooth loss. However, there has been an
annual increase in the number of studies that suggest
a strong correlation between systemic osteoporosis
and alveolar bone loss or tooth loss.8 Moreover, the
speed of alveolar bone resorption, bone remodeling,
and density of bone after tooth extraction are affected
by osteoporosis.9

Animal experimental
Fifteen male adult albino rats weighing 170–200 g were
utilized. The animals were obtained from the animal
house, the Faculty of Medicine, Cairo University and
maintained under the care of a specialized veterinarian.
All the experimental animals in all the groups
were examined clinically under anesthesia before
the administration of glucocorticoids. The animals
included in the study were normal. Each group of five
animals was kept separately in a plastic cage. They
were maintained under optimal temperature at 25°C ±
2°C with 12 h light/dark cycle and had free access to
standard rat diet and water. The study was approved
by the research ethics committee Faculty of Dentistry,
Cairo University. The procedures were designed as
per the guidelines for the responsible use of animals
in research as a part of the scientific research ethics
recommendation of the Ethical Committee, Faculty of
Dentistry, Cairo University.

Based on the previous studies, Beeraka et al., 2013
studied the clinical picture of the mouth and periodontal
status and the radiographic changes in the bone
using intra oral periapical radiography and digital
orthopantomography.10 Bouvard et al., 2013 assed
the effects of GCs on the alveolar bone and the
tibia in a mouse model with histomorphometry and
micro computed tomography.11 In 2015, the effects of
dexamethasone on the biomechanical properties of the
mandible of rats during the growth phase were assessed
using the bending test and computed tomographic
analysis. It was concluded that corticosteroid exerted
a combined, negative action on bone geometry and
volumetric bone mineral density of the cortical bone
that would exert independent effects on both the
cellular and tissue levels of biological organization of
the skeleton in the species.12 In 2018, hemi mandibles
from mice subcutaneously implanted with prednisolone
or vehicle-containing pellets for 7, 21, or 55 days were
collected for radiographic and histological analyses to
assess perilacunar/canalicular remodeling PLR. The
authors concluded that in addition to reducing bone
mass and suppressing PLR, glucocorticoids reduced
the stiffness of the mandibular bone in flexural tests.13

After one week of acclimation to the laboratory
environ ment, the rats were randomly divided
into the following three groups (n = 5). In group I
(controls), each rat was given subcutaneous injection
of 0.5 mL saline once a week for 10 weeks. Group
II [glucocorticoid induced osteoporosis (GIOP)]
rats received intramuscular injections of 7 mg/kg of
dexamethasone (Decadron, 4 mg/mL, Eipico Egypt)
once a week for 5 weeks. Group III rats received
intramuscular injections of 7 mg/kg of dexamethasone
(Decadron, 4 mg/mL, Eipico Egypt) once a week for
10 weeks.14-16
Scarification of all the animals was carried out with
ketamine overdose, and the mandibles were dissected.
We subjected the right side of each mandible for
light microscopic examination, while the left sides
of the mandibles were used for scanning electron
microscopic (SEM) examination as well as analysis of
the constituent element (calcium concentration) using
an energy dispersive radiography unit attached to the
SEM.

Thus, proper clarification of the histological and ultrastructural changes in the mandibular alveolar process,
periodontal ligament, as well as the dento-gingival
junction upon systemic use of dexamethasone need
more investigation and study. Further, the level of
calcium and phosphorus were measured using EDX
[the trabecular content of calcium (Ca) and phosphorus
(P) was analyzed] in the alveolar process of the
experimental group and compared to that in the normal
control group.

Light microscopic examination
Fixation for all the specimens was achieved in 10%
neutral formalin for 2 days. Specimens were washed,
soaked in 10% ethylene diamine tetra-acetic acid
for decalcification for one month, and then rinsed
in distilled water. Dehydration of the specimens
in ascending grades of alcohol and embedding in
paraffin and mesio-distal sectioning of the right side
of the jaw were performed. Histological sections of
5 μm thickness were prepared. The sections were
stained with hematoxylin and eosin stains using
the conventional method, and histopathological
examination was performed with light microscopy.

OBJECTIVE
The current work was undertaken to estimate and
compare the possible changes that occurred in the
mandibular alveolar process, periodontal ligament,
and the dento-gingival junction in albino rats following
short- and long-term use of glucocorticoids using
light microscopy and scanning electron microscopy.
Moreover, the quantitative composition of the calciumphosphorous complex in the studied samples was
determined with EDX spot measurement.
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Scanning electron microscopic examination
Fixation of the specimens was performed in 2.5%
glutaraldehyde in phosphate buffer (pH 7.4) for 6 h.
Thereafter, dehydration of the specimens in ascending
grades of ethanol was performed for about 10 min at
each passage and 20 min twice in absolute ethanol,
subject to critical point drying according to the
standard procedure for SEM processing, and left to dry
in air at room temperature for 3 days. The specimens
were then mounted on scanning electron microscope
stubs and studied with a Quanta 250 Field Emission
Gun (FEG) SEM (Thermo Fisher Scientific, Waltham,
USA).

of the periodontal ligament with uneven thickness on
both sides of the root exhibited area of compression and
area of tension. A large dilated blood vessel was also
seen in the periodontal ligament. Cellular cementum
appeared thicker than that in the control group with
multiple empty lacunae of cementocytes. (Figure 2, 3).
Group III exhibited severe loss of attachment of the
junctional epithelium from the tooth structure, forming
a deep periodontal pocket. Macroscopically, one of the
molars (M2) was missing in some experimental rats
(Figure 4).
Sections from the osteoporosis groups revealed
thinning of the bony trabeculae with marked widening
of the marrow spaces along with multiple resorption
foci on the bone surface and apparent vacuolization.
Lacunae of the osteocytes were empty. Multiple
reversal lines and generalized disorganized collagen
fibers in the periodontal ligaments were observed.
Hypercementosis was obvious in the cellular cementum
at the apical region (Figure 5).

Energy dispersive X-ray analysis
The quantitative composition of calcium in the studied
samples was determined with EDX spot measurement,
EDX line scan, and element mapping. The EDX analysis unit works as an integrated feature of the Quanta
250FEG SEM.
Statistical analyses
All the data obtained from the EDX analysis were
statistically evaluated. These data are represented as
mean ± SD values and were statistically compared
among the 3 studied groups. One-way analysis of
variance (ANOVA) test was performed for more than 2
independent samples, followed by Tukey’s post-hoc test
for pair wise comparisons. The results are expressed
as p-values that were considered significant at ≤ 0.05
and highly significant at ≤ 0.01. All the analyses were
performed using the following computer programs:
Microsoft Excel 2007 and Statistical Package for the
Social Science (SPSS) (SPSS Inc., IBM Corp., Armonk,
USA) v. 15 for Microsoft Windows.

Scanning electron microscopy images
The SEM images of the control group showed normal
smooth alveolar bone architecture. The neurovascular
canals were obvious. However, SEM examination of
group II demonstrated alterations in the normal bone
architecture. The bone surface revealed roughness and
widening of the neurovascular canals. The alveolar
bone of group III revealed an irregular rough resorbed
surface with a wide neurovascular canal (Figure 6).
SEM analysis of the PDL in the control group revealed
thick, well-organized collagen fiber bundles. However,
the collagen fibers of the PDL of the experimental
groups (II and III) were disorganized with areas of
degeneration seen in group III (Figure 7).

RESULTS

Energy-dispersive X-ray analysis
The EDX elemental analysis demonstrated the peak of
the chemical element – calcium (Ca) phosphorous (ph)
concentration – found in the samples in each group. The
calcium- phosphorous content in the alveolar bone was
evaluated in terms of the percent weight (wt%). EDX
quantified the relative contribution of Ca-ph element
to 100%. The mean ± SD values for total weight
percentage of calcium-phosphorous in groups I, II, and
III were calculated (Table 1). The mean total weight
percentage of calcium-phosphorous was highest in
group I, while the lowest percentage was demonstrated
in group III. ANOVA test demonstrated a statistically
significant difference among the 3 groups (p-value ≤
0.01). Post-hoc multiple comparisons between the 2
groups revealed that the difference in the mean values
of groups I and II, groups I and III, and groups II and III
were statistically significant (p-value ≤ 0.01) (Table 1).

Histological findings
The control group showed normal architecture of
the junctional epithelium and consisted of thin, nonkeratinized stratified squamous epithelium with a
straight basement membrane supported by dense
connective tissue. Histopathological examination of
the molar region showed normal histological structure
of periodontal ligaments (PDL), alveolar bone, and
cementum (Figure 1).
Group II demonstrated marked structural changes
in the form of separation of the junction epithelium
from the tooth structure forming a periodontal pocket.
Bone trabeculae appeared with randomly distributed
osteocytes as well as scalloped reversal lines. Multiple
Howship’s lacunae of the osteoclasts were also
clearly observed. Disturbed orientation, signs of
degeneration, and hyalinization of the collagen fibers
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Figure 6. Scanning electron microscope photograph of
the alveolar bone surface. (A) Normal architecture of the
alveolar bone of the control group with narrow neurovascular
canals (white arrows). (B) Rough alveolar bone surface
with widening of the neurovascular canal of group II (black
arrow). (C) Irregular rough resorbed surface with wide
neurovascular canal of group III (yellow arrow). (SEM
×1000).

Figure 1. Photomicrograph of group I (control): (A) showing
normal architecture of the junctional epithelium (arrow). (B)
Normal inter-radicular alveolar bone (AB) and periodontal
ligament (PL). (C) Normal cellular cementum (cc), apical
fibers of periodontal ligament (AF). (H&E ×200).

Figure 2. Photomicrograph of group II: (A) Showing
separation of the junctional epithelium from the tooth
structure. (B) Interdental alveolar bone revealed scalloped
reversal lines (arrows). (C) Multiple Howship’s lacunae of
osteoclasts (arrows). (H&E ×200).
Figure 7. Scanning electron microscope photograph of the
periodontal ligaments (A) Collagen fiber bundles appeared
well organized in the control group (arrows). (B) Disorganized
collagen fibers of group II (arrows). (C) Disorganized
periodontal ligament collagen bundles (arrows) with areas of
degenerations in group III (asterisk).

Table 1. Comparison of the mean values (mean ± SD) of
calcium-phosphorous complex weight percentage in the
studied groups.

Figure 3. Photomicrograph of group II: (A) exhibited area
of compression within the periodontal ligament on both
sides of the root (arrows). (B) Thin bone trabeculae (BT)
with resorbed alveolar bone surface (arrows). (H&E ×200).

Studied groups

Ca-ph weight [%]

Group I

87.24 ± 0.1607
72.153 ± 0.2291a

Group II
Group III

67.516 ± 0.1357a,b

p-value*

≤ 0.01

* ANOVA test; Tukey’s post-hoc test; a statistically significant with group I (p ≤ 0.01); b statistically significant with
group II (p ≤ 0.01).
Figure 4. Photomicrograph of group III: (A) Macroscopic
picture showing the missing second molar M2. (B) Severe
loss of attachment of the junctional epithelium from the tooth
structure (arrow). (H&E ×200).

DISCUSSION

Figure 5. Photomicrograph of group III: (A) showing multiple
resorption foci on the bone surface (arrows) and numerous
reversal lines. (B) Thinning of the bone trabeculae (BT) and
hypercementosis (HC). (C) Disorganized collagen fibers of
the periodontal ligaments (PL), multiple resorption foci on
the bone surface (arrows) and apparent vacuolization (V).
(H&E ×200).
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Bone biology and physiology are influenced by chronic
skeletal disorders, such as osteoporosis. Osteoporosis
not only affects the long bones of the body, but also may
affect jawbones, leading to alveolar bone alterations
that may compromise the handling of periodontal
disease and/or its progression.17,18
Postmenopausal estrogen deficiency is regarded as
a major cause of osteoporosis.19,20 Nevertheless, the
long-term use of glucocorticoids (GCs) may also be
considered a secondary cause of osteoporosis. We
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used a rat osteoporotic animal model because it is
cost-effective, easily available, the bone metabolism of
rats is comparable to that of humans, and rats respond
to risk factors and medication in manner similar to
that in humans.21 The most utilized animal model for
experimental osteoporosis is ovariectomy.22,23 It was
logical to utilize female rats as the animal models for
osteoporosis in the current study. However, there are
certain disadvantages. It is applicable only in female
rats; a second surgery is required and potentiates the
postmenopausal osteoporosis. As well as a shamoperated control group is required and raises the
number of rats. 24 Therefore, in the present study,
osteoporosis was induced by using dexamethasone
(DEX) as an artificial glucocorticoid (GC).

in GIO was characterized by thinning of the bone
trabeculae, perforation, and changes in terms of
trabecular connectivity. In three- dimensional analyses
with reconstructed models, perforation of bone
trabeculae was revealed in almost all the patients
treated with glucocorticoids.30
The results of our study confirmed previous reports
that have shown that prolonged administration of glucocorticoids leads to diminution of osteoblastogenesis
and accelerated apoptosis of osteoblasts and osteocyte
and that osteoclastogenesis and osteoclast survival are
provisionally increased.26 The reduction in the substitution of the resorbed bone by the osteoclasts could be
explained by the apoptosis promotion of the osteocytes
that are sensors for bone remodeling.31-34

The alterations in the alveolar process were evaluated
in the ongoing research following the administration of
dexamethasone for 5 and 10 weeks in groups II and III,
respectively. These chosen time intervals were based on
the data from previous studies and clinical trials. The
histological results of the present study coincide with
some other results that show that osteoporosis decreases
the BMD of jawbones and the height of alveolar bones,
resulting in premature loss of posterior teeth without
any signs of gingival inflammation or peridontitis.25,26
In the current study, multiple vacuoles as well as
thinning of the bone trabeculae with widening of the
marrow spaces were observed, indicating deteriorated
bone structure.

GCs also inhibit osteoblast differentiation via the
suppression of bone morphogenic protein II that
reinforces the osteoblasts transcription factors. In
addition to the repression of osteoblasts differentiation,
GCs decrease type I collagen synthesis that principally
interferes with the function of the mature cells. The
pro-apoptotic effects of glucocorticoids on osteoblasts
and osteocytes are attributable to the stimulation of
caspase-3, the key mediator of apoptosis.35 Our results
could be also explained by the fact that dexamethasone
could down regulate the osteogenic markers, such as
alkaline phosphatase, osteocalcin, and Runt-related
transcription factor 2 (Runx2).36

Hypercementosis observed in our study could be
explained as an adaptive change in the periodontal
ligament, characterized by increased thickness of the
cementum on the root surface that exceeds that required
to accomplish its normal functions and subsequently
leads to abnormal thickening with its histological
alterations. 27 Hypercementosis might explain the
response of the cementum to the degenerative changes
that affect the periodontal ligaments as a trial to
enhance the tooth anchorage. This is confirmed by Zhou
el al., who explained that the excessive apposition of
cementum in the apical half of the root may compensate
for the loss of periodontal tissue due to periodontal
disease, thus maintaining tooth attachment.28 Matter
Neto et al. also reported that hypercementosis refers
to an adaptive change in the periodontal ligament
characterized by increased cementum thickness on the
root surface much more than that necessary to fulfill its
normal functions, resulting in its abnormal thickening.29
Empty cementocytes lacunae were observed that
indicate the degeneration of osteocytes. Owing to this
hypercementosis, numerous cementocytes became
away from the source of nutrition and so degenerated
leaving the observed multiple empty lacunae.29

Dexamethasone motivates the expression of histone
deacetylase 6 (HDAC6) that binds to glucocorticoid
receptor and may prevent the osteocalcin expression.37
Other researchers concluded that dexamethasone could
reduce the expression of insulin like growth factors I
and II because these growth factors increase osteoblast
differentiation, type I collagen synthesis, and bone
38
formation.
The disorganized collagen fibers, signs of degeneration
and hyalinization of the periodontal ligament fibers,
observed in the current study were similar to previous
repor ts that have shown that osteoporosis and
decreased BMD may lead to acceleration of the clinical
attachment loss and increase the depth of periodontal
pocket postmenopausal women.39 The association of
osteoporosis and periodontitis has been confirmed,
primarily based on radiography and to a lesser degree
on clinical parameters, in most cross- sectional studies.
However, more recent studies have established that
severe periodontal disorder is not associated with
osteoporosis in postmenopausal women.40
The scanning electron microscopy results in our study
provided good support for the histological findings. The
relative content of calcium is critical for preserving the
homeostasis of mineral and the bone metabolism.41
Ca content was considered a suitable biomarker for
assessing bone health.42 EDX is a sensitive qualitative

Areas of post-osteoclastic activity were reflected by
the presence of multiple reversal lines in both groups
II and III. Our results coincide with those reported by
Chappard et al.; they showed that the microarchitecture
149
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and semiquantitative technique for assessing the
mineral content variations in calcified tissue.43

especially if chronically used, at biological bone
level. This provides new avenues for further research
concerning the treatment and inhibition of the resulting
bone disorders.

Our results were in agreement with those of Lane
et al. who studied a murine model and reported that
glucocorticoid treatment decreases the mineralization
degree of the trabecular bone. GCs may influence the
function and metabolism of osteocytes, changing the
elastic modulus around the osteocyte lacunae and
leading to reduction of the mineral- to-matrix ratios
in the same areas with an increase in the size of the
osteocyte lacunae.44
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